Orally Active and Selective Tubulin Inhibitors as Anti-Trypanosome Agents

PloS One
Vishal NanavatyBin Su

Abstract

There is an urgent need to develop a safe, effective, orally active, and inexpensive therapy for African trypanosomiasis due to the drawbacks of current drugs. Selective tubulin inhibitors have the potential to be promising drug candidates for the treatment of this disease, which is based on the tubulin protein structural difference between mammalian and trypanosome cells. We propose to identify novel tubulin inhibitors from a compound library developed based on the lead compounds that selectively target trypanosomiasis. We used Trypanosoma brucei brucei as the parasite model, and human normal kidney cells and mouse microphage cells as the host model. Growth rates of both trypanosomes and mammalian cells were determined as a means to screen compounds that selectively inhibit the proliferation of parasites. Furthermore, we examined the cell cycle profile of the parasite and compared tubulin polymerization dynamics before and after the treatment using identified compounds. Last, in vivo anti-parasite activities of these compounds were determined in T. brucei-infected mice. Three compounds were selected that are 100 fold more effective against the growth of T. brucei cells than mammalian cells. These compounds caused cell cycle pr...Continue Reading

References

Dec 1, 1981·The Journal of Cell Biology·M OkunoC J Brokaw
Oct 9, 2002·Mini Reviews in Medicinal Chemistry·Karl A Werbovetz
Apr 19, 2003·The Journal of Biological Chemistry·Tansy C HammartonJeremy C Mottram
Nov 7, 2003·Lancet·Michael P BarrettSanjeev Krishna
Jul 30, 2005·Expert Opinion on Investigational Drugs·Dietmar Steverding, Kevin M Tyler
Aug 30, 2005·Lancet·E M FèvreS C Welburn
Apr 20, 2006·Experimental Parasitology·Simon GudinHarry P de Koning
May 3, 2006·Lancet·Michael P Barrett
Aug 1, 2008·Current Clinical Pharmacology·Isa E L M Kuppens
Oct 17, 2009·Lancet·Reto BrunChristian Burri
Sep 8, 2010·Lancet·Victor Sarli Issa, Edimar Alcides Bocchi
Mar 23, 2012·Journal of Medicinal Chemistry·Xin YiBin Su
Aug 2, 2012·Bioorganic & Medicinal Chemistry Letters·Rati LamaBin Su
Jun 19, 2013·Journal of Medicinal Chemistry·Bo ZhongBin Su
May 2, 2014·European Journal of Medicinal Chemistry·Bo ZhongBin Su

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
Fluorescence Activated Cell Sorting
FACS
electrophoresis

Software Mentioned

Flowjo
GraphPad Prism

Related Concepts

Related Feeds

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.